Citations (28)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Şebnem Yılmaz, Hale Ören, Fatih Demircioğlu & Gülersu i˙rken. (2008) ASSESSMENT OF FEBRILE NEUTROPENIA EPISODES IN CHILDREN WITH ACUTE LEUKEMIA TREATED WITH BFM PROTOCOLS. Pediatric Hematology and Oncology 25:3, pages 195-204.
Read now
Read now
Kamolwish Laoprasopwattana, Pornpimol Pruekprasert, Vichai Laosombat & Malai Wongchanchailert. (2007) CLINICAL OUTCOME OF FEBRILE NEUTROPENIA IN CHILDREN WITH CANCER USING CEFTAZIDIME AND AMINOGLYCOSIDES. Pediatric Hematology and Oncology 24:8, pages 595-606.
Read now
Read now
Funda Corapcioglu, Nazan Sarper & Emine Zengin. (2006) MONOTHERAPY WITH PIPERACILLIN/TAZOBACTAM VERSUS CEFEPIME AS EMPIRICAL THERAPY FOR FEBRILE NEUTROPENIA IN PEDIATRIC CANCER PATIENTS: A Randomized Comparison. Pediatric Hematology and Oncology 23:3, pages 177-186.
Read now
Read now
Judit Müller, Miklós Garami, Tamás Constantin, Marianne Schmidt, György Fekete & Gábor Kovács. (2005) MEROPENEM IN THE TREATMENT OF FEBRILE NEUTROPENIC CHILDREN. Pediatric Hematology and Oncology 22:4, pages 277-284.
Read now
Read now
Funda Çorapçioglu & Nazan Sarper. (2005) CEFEPIME VERSUS CETAZIDIME+AMIKACIN AS EMPIRICAL THERAPY FOR FEBRILE NEUTROPENIA IN CHILDREN WITH CANCER: A Prospective Randomized Trial of the Treatment Efficacy and Cost. Pediatric Hematology and Oncology 22:1, pages 59-70.
Read now
Read now
Funda Çorapçıoğlu, Faik Sarıalioğlu, Nur Olgun & Kamer Mutafoğlu Uysal. (2004) ANALYSIS OF 136 FEBRILE NEUTROPENIC EPISODES IN CHILDREN WITH CANCER: Evaluation of Treatment Effectiveness and Cost. Pediatric Hematology and Oncology 21:6, pages 533-541.
Read now
Read now
Articles from other publishers (22)
Ryoji Kobayashi, Satoru Matsushima, Daiki Hori, Hirozumi Sano, Daisuke Suzuki, Kenji Kishimoto & Kunihiko Kobayashi. (2021) Analysis of antibiotics discontinuation during bone marrow suppression in childhood, adolescent and young adult patients with febrile neutropenia. Journal of Microbiology, Immunology and Infection 54:6, pages 1056-1060.
Crossref
Crossref
Ying Wang, Zhichao Du, Yongdong Chen, Yugang Liu & Zhitang Yang. (2021) Meta-analysis: combination of meropenem vs ceftazidime and amikacin for empirical treatment of cancer patients with febrile neutropenia. Medicine 100:8, pages e24883.
Crossref
Crossref
Hirozumi Sano, Ryoji Kobayashi, Daisuke Suzuki, Daiki Hori, Kenji Kishimoto & Kunihiko Kobayashi. (2017) A prospective randomized trial comparing piperacillin/tazobactam with meropenem as empirical antibiotic treatment of febrile neutropenic children and adolescents with hematologic and malignant disorders. Pediatric Blood & Cancer 64:6, pages e26360.
Crossref
Crossref
Paula D. RobinsonThomas LehrnbecherRobert PhillipsL. Lee DupuisLillian Sung. (2016) Strategies for Empiric Management of Pediatric Fever and Neutropenia in Patients With Cancer and Hematopoietic Stem-Cell Transplantation Recipients: A Systematic Review of Randomized Trials. Journal of Clinical Oncology 34:17, pages 2054-2060.
Crossref
Crossref
Hirozumi Sano, Ryoji Kobayashi, Daisuke Suzuki, Kenji Kishimoto, Kazue Yasuda & Kunihiko Kobayashi. (2015) Comparison between piperacillin/tazobactam and cefepime monotherapies as an empirical therapy for febrile neutropenia in children with hematological and malignant disorders: A prospective, randomized study. Pediatric Blood & Cancer 62:2, pages 356-358.
Crossref
Crossref
Ryoji Kobayashi, Daisuke Suzuki, Hirozumi Sano, Kenji Kishimoto, Kazue Yasuda & Kunihiko Kobayashi. (2014) Effect of meropenem with or without immunoglobulin as second-line therapy for pediatric febrile neutropenia. Pediatrics International 56:4, pages 526-529.
Crossref
Crossref
Gulay Sezgin, Can Acipayam, Ayse Ozkan, Ibrahim Bayram & Atila Tanyeli. (2014) Meropenem Versus Piperacillin-Tazobactam as Empiric Therapy for Febrile Neutropenia in Pediatric Oncology Patients. Asian Pacific Journal of Cancer Prevention 15:11, pages 4549-4553.
Crossref
Crossref
Mical Paul, Yaakov Dickstein, Agata Schlesinger, Simona Grozinsky-Glasberg, Karla Soares-Weiser & Leonard Leibovici. (2013) Beta-lactam versus beta-lactam-aminoglycoside combination therapy in cancer patients with neutropenia. Cochrane Database of Systematic Reviews 2016:9.
Crossref
Crossref
Heidi V. Russell, Janki Panchal, Helena VonVille, Luisa Franzini & J. Michael Swint. (2013) Economic Evaluation of Pediatric Cancer Treatment: A Systematic Literature Review. Pediatrics 131:1, pages e273-e287.
Crossref
Crossref
Mizuho Ichikawa, Daisuke Suzuki, Junjiro Ohshima, Yuko Cho, Makoto Kaneda, Akihiro Iguchi & Tadashi Ariga. (2011) Piperacillin/tazobactam versus cefozopran for the empirical treatment of pediatric cancer patients with febrile neutropenia. Pediatric Blood & Cancer 57:7, pages 1159-1162.
Crossref
Crossref
Nagua Giurici & Giulio Zanazzo. (2011) Consensus on Diagnosis and Empiric Antibiotic Therapy of Febrile Neutropenia. Pediatric Reports 3:1, pages e4.
Crossref
Crossref
Elisabeth E. Adderson, Patricia M. Flynn & James M. Hoffman. (2010) Efficacy and Safety of Cefepime in Pediatric Patients: A Systematic Review and Meta-Analysis. The Journal of Pediatrics 157:3, pages 490-495.e1.
Crossref
Crossref
X. Durrmeyer & R. Cohen. (2010) Utilisation des carbapénèmes en pédiatrie. Archives de Pédiatrie 17, pages S163-S170.
Crossref
Crossref
Vedat Uygun, Gulsun Tezcan Karasu, Dilara Ogunc, Akif Yesilipek & Volkan Hazar. (2009) Piperacillin/tazobactam versus cefepime for the empirical treatment of pediatric cancer patients with neutropenia and fever: A randomized and open‐label study. Pediatric Blood & Cancer 53:4, pages 610-614.
Crossref
Crossref
Ryoji Kobayashi, Tomonobu Sato, Masahide Nakajima, Makoto Kaneda & Akihiro Iguchi. (2009) Piperacillin/Tazobactam Plus Ceftazidime Versus Sulbactam/Ampicillin Plus Aztreonam as Empirical Therapy for Fever in Severely Neutropenic Pediatric Patients. Journal of Pediatric Hematology/Oncology 31:4, pages 270-273.
Crossref
Crossref
Stéphane Paulus & Simon Dobson. 2009. Hot Topics in Infection and Immunity in Children V. Hot Topics in Infection and Immunity in Children V
185
204
.
David Isaacs, Elizabeth Elliott, Ruth Gilbert, Virginia Moyer & Michael Pichichero. 2007. Evidence‐based Pediatric Infectious Diseases. Evidence‐based Pediatric Infectious Diseases
117
131
.
E. J. Bow, C. Rotstein, G. A. Noskin, M. L. re, A. P. Schwarer, B. H. Segal, J. F. Seymour, J. Szer & S. Sanche. (2006) A Randomized, Open-Label, Multicenter Comparative Study of the Efficacy and Safety of Piperacillin-Tazobactam and Cefepime for the Empirical Treatment of Febrile Neutropenic Episodes in Patients with Hematologic Malignancies. Clinical Infectious Diseases 43:4, pages 447-459.
Crossref
Crossref
Jean Klastersky. (2004) Management of Fever in Neutropenic Patients with Different Risks of Complications. Clinical Infectious Diseases 39:s1, pages S32-S37.
Crossref
Crossref
Mical Paul, Agata Schlesinger, Simona Grozinsky-Glasberg, Karla Soares-Weiser & Leonard Leibovici. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
V. C. Costa, M. B. Ferraz, A. S. Petrilli, C. A. Pereira & J. W. Rogerio. (2003) Resource utilization and cost of episodes of febrile neutropenia in children with acute leukemias and lymphomas. Supportive Care in Cancer 11:6, pages 356-361.
Crossref
Crossref
Claudio Viscoli & Elio Castagnola. (2002) Treatment of febrile neutropenia: what is new?. Current Opinion in Infectious Diseases 15:4, pages 377-382.
Crossref
Crossref